Skip to Main Content

Paper Details

Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial.
Int J Cardiol
3
2023
AF, CV, CV death, CV events, Edoxaban, MACE, NLR, Neutrophil, atrial fibrillation, cardiovascular death, edoxaban, lymphocyte, neutrophil, patients, stroke, systemic embolism, warfarin, white blood cell
Author NameAffiliation
David A MorrowBrigham and Women's Hospital
David A MorrowBrigham and Women's Hospital
Elliott M AntmanBrigham and Women's Hospital
Eugene BraunwaldBrigham and Women's Hospital
Robert P GiuglianoBrigham and Women's Hospital
  • 1 - 5

Datasets

Release 1.2